Life sciences news
-
Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate
Thursday September 24th 2020
Read more
-
Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study
Tuesday September 22nd 2020
Read more
-
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
Friday September 11th 2020
Read more
-
Oxurion NV reports first patient dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Tuesday September 1st 2020
Read more
-
Precigen ActoBio announces positive topline results from Phase 1b study of AG019 ActoBiotics
Tuesday August 11th 2020
Read more
-
Mithra announces shelf life extension for Myring™ to 36 months
Tuesday August 4th 2020
Read more
-
Gilead en Galapagos kondigen positieve Europese CHMP opinie aan voor Jyseleca® (Filgotinib) voor de behandeling van volwassenen met matige tot ernstige reumatoïde artritis
Friday July 24th 2020
Read more
-
Aligos Therapeutics and KU Leuven announce collaboration for the development of a therapeutic candidate targeting Coronavirus
Thursday July 2nd 2020
Read more
-
Become a flanders.bio member
Your news here?
-
US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings
Friday June 26th 2020
Read more
-
eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Wednesday June 17th 2020
Read more
-
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate
Thursday June 11th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
